Custom Search
|
Tuesday, March 9th, 2010 | Posted by apons80 HEADLINE STOCKS-U.S. small/midcap stocks to watch on March 9(For large-cap stocks to watch, click on [WATCH/US]) March 9 (Reuters) - Some small and midcap stocks to watch on Tuesday: JONES SODA CO (JSDA.O: Quote, Profile, Research), $0.50, down 40 pct The struggling soft drink maker signed a letter of intent to be acquired by Reeds Inc (REED.O: Quote, Profile, Research) in a cash-and-stock deal worth about $9.7 million. [ID:nSGE6280ED] CERUS CORP (CERS.O: Quote, Profile, Research), $2.67, up 13 pct Robert W. Baird upgraded the blood safety products maker to "outperform" from "neutral," and said the market is undervaluing the company's Intercept red blood cell system. [ID:SGE6280GY] SUSQUEHANNA BANCSHARES INC (SUSQ.O: Quote, Profile, Research), $8.61, down 5 pct The company on Monday said it will offer common shares to raise $300 million partly to support future acquisitions, including FDIC-assisted acquisition transactions or to pay back U.S. Treasury's funds. [ID:nSGE6270L0] AGFEED INDUSTRIES INC (FEED.O: Quote, Profile, Research), $5.30, up 18 pct The company reported better-than-expected full-year earnings helped by increased production volumes in the company's hog division and animal nutrition divisions. [ID:nWNAB6928] MICROVISION INC (MVIS.O: Quote, Profile, Research), $2.55, down 10 pct The portable projector maker on Monday posted a narrower quarterly loss that was in line with analysts' view, but revenue fell short of market expectations. [ID:nSGE6270LL] IMMUNOGEN INC (IMGN.O: Quote, Profile, Research), $7.68, up 4 pct The drugmaker said on Monday its experimental skin cancer drug received orphan drug designation from U.S. and European health regulators. [ID:nSGE6270L7] EXELIXIS INC (EXEL.O: Quote, Profile, Research), $6.81, Monday's close The cancer drug developer posted a quarterly loss in line with market expectations, and forecast a full-year revenue above consensus estimates. [ID:SGE6280F5] MATRIXX INITIATIVES (MTXX.O: Quote, Profile, Research), $4.87, Monday's close The pharmaceuticals company said U.S. health regulators declined to withdraw the warning letter on the company's nasal versions of Zicam cold remedy. [ID:SGE6280EX] Stock Market Investing (Reporting by Mansi Dutta in Bangalore) HEADLINE STOCKS-U.S. small/midcap stocks to watch on March 9Comments are closed |
Related Stock Market News
Republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters and the Reuters sphere logo are registered trademarks or trademarks of the Reuters group of companies around the world. Reuters in no mean sponsor or is associated to this website.
|
Popular Sections:
Today's Market Activity |
Markets Overview |
Stock Market News |
Currencies |
Mutual Funds |
Market Calculators |
My Portfolio |
Stock Market Tracker
Popular Tags: stock market today | stock research | stock quotes | stock analysis | market report | stock trading | stock charts | foreign market | energy market | treasurys
ABOUT US | ADVERTISE | NEWSROOM | CONTACT US | TERMS OF SERVICE | PRIVACY POLICY | SITEMAP
Best Growth Stock LLC. World Leader In Today's Stock Market Trading Analysis, Report & Research. Copyright . All rights reserved.
Popular Tags: stock market today | stock research | stock quotes | stock analysis | market report | stock trading | stock charts | foreign market | energy market | treasurys
ABOUT US | ADVERTISE | NEWSROOM | CONTACT US | TERMS OF SERVICE | PRIVACY POLICY | SITEMAP
Best Growth Stock LLC. World Leader In Today's Stock Market Trading Analysis, Report & Research. Copyright . All rights reserved.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
Stock News provided by MarketMinute.com & Reuters.
Stock Analysis provided by SocialPicks. Conference calls information supplied by OpenCompany.
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs.